Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-10-09

Yong Zhu

Federal Grant PI High Impact

Professor

CPH | Epidemiology

41 h-index 135 pubs 5,411 cited

  • Humans
  • Female
  • Male
  • Animals
  • Middle Aged
  • Aged
  • Polymorphism, Single Nucleotide
  • Adult
  • Genetic Predisposition to Disease
  • Circadian Rhythm
  • Case-Control Studies
  • Mice
  • Polymorphism, Genetic
  • Risk Factors
  • Cell Line, Tumor

Biography and Research Information

OverviewAI-generated summary

Yong Zhu is a molecular epidemiologist whose research focuses on identifying biomarkers associated with cancer risk, progression, and survival, with an emphasis on their translational implications. His laboratory investigates the impact of circadian factors, including night shift work and variations in circadian genes, on tumorigenesis. Additionally, his work involves translational research into small noncoding RNAs, exploring their role in disease processes.

Dr. Zhu's research has been supported by federal grants, including an NIH/National Cancer Institute award of $411,876 to explore piRNAs as potential biomarkers for early ovarian cancer detection. His scholarly contributions are evidenced by a high-impact researcher designation, with an h-index of 41 and over 5,400 citations across 135 publications. He leads a research group and maintains an active laboratory website, fostering collaboration within the University of Arkansas for Medical Sciences with individuals such as Yujuan Guo and Danny Baxter.

Metrics

  • h-index: 41
  • Publications: 135
  • Citations: 5,411

Positions

  • Professor 2024–present
    University of Arkansas for Medical Sciences CPH | Epidemiology Institutional directory

Selected Publications

  • hsa_circ_0063865 regulates cytoskeleton rearrangement and endoplasmic reticulum stress to promote esophageal tumorigenesis under co-exposure to N-nitrosamines and microcystin (2026)
    Journal of Translational Medicine DOI OpenAlex
  • Abstract 6243: Mapping risk: spatial analysis of 2,4-D herbicide emissions and colorectal cancer. (2026)
    Cancer Research DOI OpenAlex
  • Abstract 3590: Genetic and immune signaling divergence underlies the inverse associationbetween asthma and cancer. (2026)
    Cancer Research DOI OpenAlex
  • Mapping risk: Spatial analysis of 2,4-D herbicide emissions and colorectal cancer (2025)
    Environmental Challenges DOI OpenAlex
  • Abstract 2792: PiRNA as a novel therapeutic in hepatocellular carcinoma: insights from population screening (2025)
    Cancer Research 1 citation DOI OpenAlex
  • Abstract 056: Exposure to artificial light at night in relation to weight gain and cardiovascular risk among women cancer survivors (2025)
    Circulation DOI OpenAlex

View all publications on OpenAlex →

Federal Grants 1 $411,876 total

NIH Contact PI May 2024 - Apr 2027

Explore piRNAs as a novel group of biomarkers for ovarian cancer early detection

National Cancer Institute $411,876 R21

Grants & Funding

As listed on this researcher's institutional profile. Federal awards with verified records are shown above.

  • ABI C. OBrien NIH COBRE FY26 Y4 State of Arkansas Principal Investigator
  • Zhu 2025-2027 Rural Research Award Program CI Cancer Institute Principal Investigator

Collaboration Network

34 Collaborators 14 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics